Lovastatin


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000690 Amyotrophic Lateral Sclerosis PMID:29427042
MESH:D000743 Anemia, Hemolytic PMID:7653497
MESH:D000799 Angioedema PMID:10084510
MESH:D000855 Anorexia PMID:7867482
MESH:D000857 Olfaction Disorders PMID:1388478
MESH:D001068 Feeding and Eating Disorders PMID:7909021
MESH:D002493 Central Nervous System Diseases PMID:15987932
MESH:D002779 Cholestasis PMID:2026107; PMID:8439902
MESH:D002780 Cholestasis, Intrahepatic PMID:7867482
MESH:D003882 Dermatomyositis PMID:8944218
MESH:D004401 Dysarthria PMID:15596782
MESH:D005076 Exanthema PMID:3055921
MESH:D005483 Flushing PMID:12685616
MESH:D005767 Gastrointestinal Diseases PMID:8481075
MESH:D006261 Headache PMID:8221476
MESH:D006330 Heart Defects, Congenital PMID:15987932
MESH:D006987 Hypesthesia PMID:10027656; PMID:7484806
MESH:D007319 Sleep Initiation and Maintenance Disorders PMID:3055921; PMID:8481075
MESH:D007565 Jaundice PMID:7867482
MESH:D007676 Kidney Failure, Chronic PMID:8918723
MESH:D008113 Liver Neoplasms PMID:25058030
MESH:D009120 Muscle Cramp PMID:2572816
MESH:D009135 Muscular Diseases PMID:10217378; PMID:10799017; PMID:11058722; PMID:12139858; PMID:19027590; PMID:19496270; PMID:1985608; PMID:2067654; PMID:2355431; PMID:2572817; PMID:3055921; PMID:7650497; PMID:7942524; PMID:8360706; PMID:8480959; PMID:8481075; PMID:8729588
MESH:D009212 Myoglobinuria PMID:3076126; PMID:8360706
MESH:D009220 Myositis PMID:16089017; PMID:1615846; PMID:3275891
MESH:D009336 Necrosis PMID:18034278; PMID:9605009
MESH:D009846 Oliguria PMID:8767987
MESH:D010146 Pain PMID:10217378; PMID:12353945; PMID:17200428
MESH:D010292 Paresthesia PMID:7484806; PMID:8172444
MESH:D010523 Peripheral Nervous System Diseases PMID:7484806; PMID:9671841
MESH:D011115 Polyneuropathies PMID:12011277
MESH:D011507 Proteinuria PMID:8225831
MESH:D012206 Rhabdomyolysis PMID:2017280; PMID:2253372; PMID:2297197; PMID:2355431; PMID:3275891; PMID:3290520; PMID:8252847; PMID:8767987; PMID:8918723; PMID:9350151
MESH:D012817 Signs and Symptoms, Digestive PMID:3055921
MESH:D012893 Sleep Wake Disorders PMID:7909021; PMID:8238075
MESH:D013262 Stevens-Johnson Syndrome PMID:25811541
MESH:D013733 Testicular Diseases PMID:17200428
MESH:D014581 Urticaria PMID:10084510
MESH:D015431 Weight Loss PMID:33408297
MESH:D017240 Mitochondrial Myopathies PMID:12353945
MESH:D018771 Arthralgia PMID:8481075
MESH:D018908 Muscle Weakness PMID:12353945; PMID:1521554; PMID:17049607; PMID:2572816; PMID:7484806; PMID:9244616
MESH:D019964 Mood Disorders PMID:8238075
MESH:D041781 Jaundice, Obstructive PMID:2026107; PMID:2322916
MESH:D051437 Renal Insufficiency PMID:3076126; PMID:8252847; PMID:8360706
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:1559791; PMID:22331495; PMID:24014644; PMID:33814510; PMID:7867482; PMID:8999220; PMID:9350151
MESH:D058186 Acute Kidney Injury PMID:2253372; PMID:2297197; PMID:2355431; PMID:3275891; PMID:3290520; PMID:8767987; PMID:9350151
MESH:D064420 Drug-Related Side Effects and Adverse Reactions PMID:2017280

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.